Skip to main content
. 2018 Apr 10;9(27):19368–19378. doi: 10.18632/oncotarget.25053

Figure 4. Total and relative cfDNA levels in stage I and IV NSCLC patients before and after radiotherapy.

Figure 4

Total and relative cfDNA levels in (A) stage I–II and (B) stage IV NSCLC patients at pre-RT, during RT and post-RT is shown. Note: Continuous variables were compared using Student’s t-test and P < 0.05 was considered statistically significant compared to pre-RT; RT, radiotherapy.